go back

Brexucabtagene Autoleucel (Tecartus)

California rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $645,654 · 10th–90th $645,654$645,6540%50%100%$645,654Professionalmedian $446,684 · 10th–90th $129$977,2370%20%40%10th90th$446,684$100.0$500.0$2.0K$10.0K$50.0K$200.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$128.82
Median
$398.11
Typical High
$831.76
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$645,654.23
Median
$645,654.23
Typical High
$645,654.23
Lucent Health
Setting
Professional
Modifier
Global
Typical Low
$977,237.22
Median
$977,237.22
Typical High
$977,237.22
United
Setting
Professional
Modifier
Global
Typical Low
$446,683.59
Median
$446,683.59
Typical High
$489,778.82